The basics of epithelial-mesenchymal transition

Journal of Clinical Investigation

Volumn 119, Issue 6, 2009, Pages 1420-1428

  Kalluri, Raghu ^a,b,c   Weinberg, Robert A ^d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; GROWTH FACTOR;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CANCER INVASION; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; CELL TRANSFORMATION; EMBRYO DEVELOPMENT; EPITHELIUM CELL; FIBROSIS; MESENCHYME CELL; METASTASIS; NEURAL CREST; NIDATION; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; CELL DIFFERENTIATION; EPITHELIAL CELLS; FIBROSIS; HUMANS; MESENCHYMAL STEM CELLS; NEOPLASMS; REGENERATION;

EID: 67650999875     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI39104     Document Type: Review

References (130)

1. Kalluri, R., and Neilson, E.G. 2003. Epithelialmesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112:1776-1784.
2. Hay, E.D. 1995. An overview of epithelio-mesenchymal transformation. Acta Anat. (Basel). 154:8-20.
3. Lipschutz, J.H. 1998. Molecular development of the kidney: a review of the results of gene disruption studies. Am. J. Kidney Dis. 31:383-397.
4. Rothenpieler, U.W., and Dressler, G.R. 1993. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development. 119:711-720.
5. Hogan, B.L., and Kolodziej, P.A. 2002. Organogenesis: molecular mechanisms of tubulogenesis. Nat. Rev. Genet. 3:513-523.
6. Virchow, R. 1858. Die Cellularpathologie in ihrer Begruendung auf physiologische und pathologische Gewebelehre. August Hirschwald. Berlin, Germany.
7. Lee, J.M., Dedhar, S., Kalluri, R., and Thompson, E.W. 2006. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172:973-981.
8. Zeisberg, M., and Neilson, E.G. 2009. Biomarkers for epithelial- mesenchymal transitions. J. Clin. Invest. 119:1429-1437.
9. Vicovac, L., and Aplin, J.D. 1996. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat. (Basel). 156:202-216.
10. Aplin, J.D., Haigh, T., Vicovac, L., Church, H.J., and Jones, C.J. 1998. Anchorage in the developing placenta: an overlooked determinant of pregnancy outcome? Hum. Fertil. (Camb.). 1:75-79.
11. Bischof, P., et al. 2006. Implantation of the human embryo: research lines and models. From the implantation research network 'Fruitful'. Gynecol. Obstet. Invest. 62:206-216.
12. Acloque, H., Adams, M.S., Fishwick, K., Bronner-Fraser, M., and Nieto, M.A. 2009. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 119:1438-1449.
13. Hay, E.D. 1990. Role of cell-matrix contacts in cell migration and epithelial-mesenchymal transformation. Cell Differ. Dev. 32:367-375.
14. Thiery, J.P., and Sleeman, J.P. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7:131-142.
15. Hay, E.D. 2005. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn. 233:706-720.
16. Skromne, I., and Stern, C.D. 2001. Interactions between Wnt and Vg1 signalling pathways initiate primitive streak formation in the chick embryo. Development. 128:2915-2927.
17. Liu, P., et al. 1999. Requirement for Wnt3 in vertebrate axis formation. Nat. Genet. 22:361-365.
18. Popperl, H., et al. 1997. Misexpression of Cwnt8C in the mouse induces an ectopic embryonic axis and causes a truncation of the anterior neuroectoderm. Development. 124:2997-3005.
19. Thomas, P., Brickman, J.M., Popperl, H., Krumlauf, R., and Beddington, R.S. 1997. Axis duplication and anterior identity in the mouse embryo. Cold Spring Harb. Symp. Quant. Biol. 62:115-125.
20. Chea, H.K., Wright, C.V., and Swalla, B.J. 2005. Nodal signaling and the evolution of deuterostome gastrulation. Dev. Dyn. 234:269-278.
21. Skromne, I., and Stern, C.D. 2002. A hierarchy of gene expression accompanying induction of the primitive streak by Vg1 in the chick embryo. Mech. Dev. 114:115-118.
22. Collignon, J., Varlet, I., and Robertson, E.J. 1996. Relationship between asymmetric nodal expression and the direction of embryonic turning. Nature. 381:155-158.
23. Varlet, I., Collignon, J., and Robertson, E.J. 1997. nodal expression in the primitive endoderm is required for specification of the anterior axis during mouse gastrulation. Development. 124:1033-1044.
24. Shah, S.B., et al. 1997. Misexpression of chick Vg1 in the marginal zone induces primitive streak formation. Development. 124:5127-5138.
25. Ciruna, B., and Rossant, J. 2001. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev. Cell. 1:37-49.
26. Rossant, J., Ciruna, B., and Partanen, J. 1997. FGF signaling in mouse gastrulation and anteroposterior patterning. Cold Spring Harb. Symp. Quant. Biol. 62:127-133.
27. Zhao, H., et al. 2006. Fibroblast growth factor receptor 1 (Fgfr1) is not essential for lens fiber differentiation in mice. Mol. Vis. 12:15-25.
28. Perea-Gomez, A., et al. 2002. Nodal antagonists in the anterior visceral endoderm prevent the formation of multiple primitive streaks. Dev. Cell. 3:745-756.
29. Lindsley, R.C., et al. 2008. Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell. 3:55-68.
30. Arnold, S.J., Hofmann, U.K., Bikoff, E.K., and Robertson, E.J. 2008. Pivotal roles for eomesodermin during axis formation, epithelium-to-mesenchyme transition and endoderm specification in the mouse. Development. 135:501-511.
31. Nieto, M.A. 2002. The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol. 3:155-166.
32. Ikenouchi, J., Sasaki, H., Tsukita, S., and Furuse, M. 2008. Loss of occludin affects tricellular localization of tricellulin. Mol. Biol. Cell. 19:4687-4693.
33. Cavatorta, A.L., Giri, A.A., Banks, L., and Gardiol, D. 2008. Cloning and functional analysis of the promoter region of the human Disc large gene. Gene. 424:87-95.
34. Whiteman, E.L., Liu, C.J., Fearon, E.R., and Margolis, B. 2008. The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes. Oncogene. 27:3875-3879.
35. Duband, J.L., and Thiery, J.P. 1982. Appearance and distribution of fibronectin during chick embryo gastrulation and neurulation. Dev. Biol. 94:337-350.
36. Sauka-Spengler, T., and Bronner-Fraser, M. 2008. A gene regulatory network orchestrates neural crest formation. Nat. Rev. Mol. Cell Biol. 9:557-568.
37. Knecht, A.K., and Bronner-Fraser, M. 2002. Induction of the neural crest: a multigene process. Nat. Rev. Genet. 3:453-461.
38. Liem, K.F., Jr., Jessell, T.M., and Briscoe, J. 2000. Regulation of the neural patterning activity of sonic hedgehog by secreted BMP inhibitors expressed by notochord and somites. Development. 127:4855-4866.
39. Villanueva, S., Glavic, A., Ruiz, P., and Mayor, R. 2002. Posteriorization by FGF, Wnt, and retinoic acid is required for neural crest induction. Dev. Biol. 241:289-301.
40. Karafiat, V., Dvorakova, M., Pajer, P., Cermak, V., and Dvorak, M. 2007. Melanocyte fate in neural crest is triggered by Myb proteins through activation of c-kit. Cell Mol. Life Sci. 64:2975-2984.
41. Burstyn-Cohen, T., Stanleigh, J., Sela-Donenfeld, D., and Kalcheim, C. 2004. Canonical Wnt activity regulates trunk neural crest delamination linking BMP/noggin signaling with G1/S transition. Development. 131:5327-5339.
42. Sela-Donenfeld, D., and Kalcheim, C. 2002. Localized BMP4-noggin interactions generate the dynamic patterning of noggin expression in somites. Dev. Biol. 246:311-328.
43. Thiery, J.P. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15:740-746.
44. Potenta, S., Zeisberg, E., and Kalluri, R. 2008. The role of endothelial-to-mesenchymal transition in cancer progression. Br. J. Cancer. 99:1375-1379.
45. Zeisberg, E.M., et al. 2007. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13:952-961.
46. Zeisberg, M., et al. 2007. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282:23337-23347.
47. Kim, K.K., et al. 2006. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. U. S. A. 103:13180-13185.
48. Strutz, F., et al. 1995. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 130:393-405.
49. Okada, H., Danoff, T.M., Kalluri, R., and Neilson, E.G. 1997. Early role of Fsp1 in epithelial-mesenchymal transformation. Am. J. Physiol. 273:F563-F574.
50. Rastaldi, M.P., et al. 2002. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int. 62:137-146.
51. Zeisberg, M., et al. 2003. BMP-7 counteracts TGFbeta-1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9:964-968.
52. Okada, H., Strutz, F., Danoff, T.M., Kalluri, R., and Neilson, E.G. 1996. Possible mechanisms of renal fibrosis. Contrib. Nephrol. 118:147-154.
53. Zavadil, J., and Bottinger, E.P. 2005. TGF-beta and epithelial-to- mesenchymal transitions. Oncogene. 24:5764-5774.
54. Ekblom, P. 1996. Genetics of kidney development. Curr. Opin. Nephrol. Hypertens. 5:282-287.
55. Aufderheide, E., Chiquet-Ehrismann, R., and Ekblom, P. 1987. Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J. Cell Biol. 105:599-608.
56. Ivanova, L., Butt, M.J., and Matsell, D.G. 2008. Mesenchymal transition in kidney collecting duct epithelial cells. Am. J. Physiol. Renal Physiol. 294:F1238-F1248.
57. Strutz, F., et al. 2002. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int. 61:1714-1728.
58. Yang, J., et al. 2002. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J. Clin. Invest. 110:1525-1538.
59. Yang, J., and Liu, Y. 2002. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nephrol. 13:96-107.
60. Li, Y., Yang, J., Dai, C., Wu, C., and Liu, Y. 2003. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J. Clin. Invest. 112:503-516.
61. Kim, K., Lu, Z., and Hay, E.D. 2002. Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int. 26:463-476.
62. Nawshad, A., Lagamba, D., Polad, A., and Hay, E.D. 2005. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs. 179:11-23.
63. Zeisberg, M., et al. 2003. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am. J. Physiol. Renal Physiol. 285:F1060-F1067.
64. Bataille, F., et al. 2008. Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflamm. Bowel Dis. 14:1514-1527.
65. Hanahan, D., and Weinberg, R.A. 2000. The hallmarks of cancer. Cell. 100:57-70.
66. Thiery, J.P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2:442-454.
67. Yang, J., and Weinberg, R.A. 2008. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell. 14:818-829.
68. Fidler, I.J., and Poste, G. 2008. The "seed and soil" hypothesis revisited. Lancet Oncol. 9:808.
69. Brabletz, T., et al. 2001. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. U. S. A. 98:10356-10361.
70. Zeisberg, M., Shah, A.A., and Kalluri, R. 2005. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 280:8094-8100.
71. Jechlinger, M., Grunert, S., and Beug, H. 2002. Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling. J. Mammary Gland Biol. Neoplasia. 7:415-432.
72. Bissell, M.J., Radisky, D.C., Rizki, A., Weaver, V.M., and Petersen, O.W. 2002. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation. 70:537-546.
73. Smit, M.A., and Peeper, D.S. 2008. Deregulating EMT and senescence: double impact by a single twist. Cancer Cell. 14:5-7.
74. Ansieau, S., et al. 2008. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 14:79-89.
75. Weinberg, R.A. 2008. Twisted epithelial-mesenchymal transition blocks senescence. Nat. Cell Biol. 10:1021-1023.
76. Shi, Y., and Massague, J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 113:685-700.
77. Niessen, K., et al. 2008. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J. Cell Biol. 182:315-325.
78. Medici, D., Hay, E.D., and Olsen, B.R. 2008. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol. Biol. Cell. 19:4875-4887.
79. Kokudo, T., et al. 2008. Snail is required for TGF{beta}-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J. Cell. Sci. 121:3317-3324.
80. Tse, J.C., and Kalluri, R. 2007. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J. Cell. Biochem. 101:816-829.
81. Gupta, P.B., Mani, S., Yang, J., Hartwell, K., and Weinberg, R.A. 2005. The evolving portrait of cancer metastasis. Cold Spring Harb. Symp. Quant. Biol. 70:291-297.
82. Yang, J., Mani, S.A., and Weinberg, R.A. 2006. Exploring a new twist on tumor metastasis. Cancer Res. 66:4549-4552.
83. Mani, S.A., et al. 2007. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl. Acad. Sci. U. S. A. 104:10069-10074.
84. Mani, S.A., et al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704-715.
85. Hartwell, K.A., et al. 2006. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc. Natl. Acad. Sci. U. S. A. 103:18969-18974.
86. Taki, M., Verschueren, K., Yokoyama, K., Nagayama, M., and Kamata, N. 2006. Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Int. J. Oncol. 28:487-496.
87. Bierie, B., and Moses, H.L. 2006. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer. 6:506-520.
88. Oft, M., Heider, K.H., and Beug, H. 1998. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8:1243-1252.
89. Hata, A., Shi, Y., and Massague, J. 1998. TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads. Mol. Med. Today. 4:257-262.
90. Song, J. 2007. EMT or apoptosis: a decision for TGF-beta. Cell Res. 17:289-290.
91. Miyazono, K., ten Dijke, P., and Heldin, C.H. 2000. TGF-beta signaling by Smad proteins. Adv. Immunol. 75:115-157.
92. Derynck, R., Akhurst, R.J., and Balmain, A. 2001. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29:117-129.
93. Heldin, C.H., Miyazono, K., and ten Dijke, P. 1997. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:465-471.
94. Roberts, A.B., et al. 2006. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev. 17:19-27.
95. Piek, E., Moustakas, A., Kurisaki, A., Heldin, C.H., and ten Dijke, P. 1999. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell. Sci. 112:4557-4568.
96. Bhowmick, N.A., et al. 2001. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell. 12:27-36.
97. Saika, S., et al. 2004. Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab. Invest. 84:1259-1270.
98. Yang, L., Lin, C., and Liu, Z.R. 2006. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin. Cell. 127:139-155.
99. Eger, A., Stockinger, A., Schaffhauser, B., Beug, H., and Foisner, R. 2000. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J. Cell Biol. 148:173-188.
100. Stockinger, A., Eger, A., Wolf, J., Beug, H., and Foisner, R. 2001. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J. Cell Biol. 154:1185- 1196.
101. Bhowmick, N.A., Zent, R., Ghiassi, M., McDonnell, M., and Moses, H.L. 2001. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276:46707-46713.
102. Lee, Y.H., Albig, A.R., Maryann, R., Schiemann, B.J., and Schiemann, W.P. 2008. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis. 29:2243-2251.
103. Lehmann, K., et al. 2000. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14:2610-2622.
104. Gotzmann, J., et al. 2002. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J. Cell. Sci. 115:1189-1202.
105. Oft, M., et al. 1996. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10:2462-2477.
106. Janda, E., et al. 2002. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156:299-313.
107. Cui, W., et al. 1996. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 86:531-542.
108. Watanabe, T., et al. 2001. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 344:1196-1206.
109. Neil, J.R., Johnson, K.M., Nemenoff, R.A., and Schiemann, W.P. 2008. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms. Carcinogenesis. 29:2227-2235.
110. Thiery, J.P., and Huang, R. 2005. Linking epithelial-mesenchymal transition to the well-known polarity protein Par6. Dev. Cell. 8:456-458.
111. Tepass, U., Truong, K., Godt, D., Ikura, M., and Peifer, M. 2000. Cadherins in embryonic and neural morphogenesis. Nat. Rev. Mol. Cell Biol. 1:91-100.
112. Edelman, G.M., Gallin, W.J., Delouvee, A., Cunningham, B.A., and Thiery, J.P. 1983. Early epochal maps of two different cell adhesion molecules. Proc. Natl. Acad. Sci. U. S. A. 80:4384-4388.
113. Reichmann, E., et al. 1992. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell. 71:1103-1116.
114. Gottardi, C.J., Wong, E., and Gumbiner, B.M. 2001. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell Biol. 153:1049-1060.
115. Muta, H., et al. 1996. E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn. J. Cancer Res. 87:843-848.
116. Saito, A., et al. 1999. Disruption of E-cadherin-mediated cell adhesion systems in gastric cancers in young patients. Jpn. J. Cancer Res. 90:993-999.
117. Hirohashi, S. 1998. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153:333-339.
118. Birchmeier, W., and Behrens, J. 1994. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta. 1198:11-26.
119. Blanco, M.J., et al. 2002. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 21:3241-3246.
120. Comijn, J., et al. 2001. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell. 7:1267-1278.
121. Van de Putte, T., et al. 2003. Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. Am. J. Hum. Genet. 72:465-470.
122. Yokoyama, K., et al. 2001. Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol. 37:65-71.
123. Yang, J., et al. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 117:927-939.
124. Radisky, D.C., et al. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 436:123-127.
125. Korpal, M., Lee, E.S., Hu, G., and Kang, Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283:14910-14914.
126. Park, S.M., Gaur, A.B., Lengyel, E., and Peter, M.E. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22:894-907.
127. Gregory, P.A., et al. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10:593-601.
128. Paterson, E.L., et al. 2008. The microRNA-200 family regulates epithelial to mesenchymal transition. Scientific World Journal. 8:901-904.
129. Gregory, P.A., Bracken, C.P., Bert, A.G., and Goodall, G.J. 2008. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle. 7:3112-3118.
130. Zavadil, J., Narasimhan, M., Blumenberg, M., and Schneider, R.J. 2007. Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs. 185:157-161.